Heslop HE - Search Results

1

XomaZyme-CD5 immunotoxin in conjunction with partial T cell depletion for prevention of graft rejection and graft-versus-host disease after bone marrow transplantation from matched unrelated donors.

Koehler M, Hurwitz CA, Krance RA, Coustan-Smith E, Williams LL, Santana V, Ribeiro RC, Brenner MK, Heslop HE. Koehler M, et al. Among authors: heslop he. Bone Marrow Transplant. 1994 May;13(5):571-5. Bone Marrow Transplant. 1994. PMID: 7519937

2

Reconstitution of the T cell receptor alpha beta repertoire in recipients of allogeneic BMT.

Rencher SD, Hanif I, Heslop HE, Turner VE, Brenner MK, Hurwitz JL. Rencher SD, et al. Among authors: heslop he. Bone Marrow Transplant. 1992 Dec;10(6):521-7. Bone Marrow Transplant. 1992. PMID: 1490202

3

IL-2 infusion abrogates humoral immune responses in humans.

Gottlieb DJ, Prentice HG, Heslop HE, Bello C, Brenner MK. Gottlieb DJ, et al. Among authors: heslop he. Clin Exp Immunol. 1992 Mar;87(3):493-8. doi: 10.1111/j.1365-2249.1992.tb03025.x. Clin Exp Immunol. 1992. PMID: 1544235 Free PMC article.

4

Immunotherapy of leukemia.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Leukemia. 1992;6 Suppl 1:76-9. Leukemia. 1992. PMID: 1548941 Review.

5

Graft-versus-host reactions and bone-marrow transplantation.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Curr Opin Immunol. 1991 Oct;3(5):752-7. doi: 10.1016/0952-7915(91)90108-d. Curr Opin Immunol. 1991. PMID: 1836732

6

Homeostatic action of interleukin-4 on endogenous and recombinant interleukin-2-induced activated killer cell function.

Bello-Fernandez C, Bird C, Heslop HE, Gottlieb DJ, Reittie JE, Rill DM, Holland M, Prentice HG, Brenner MK. Bello-Fernandez C, et al. Among authors: heslop he. Blood. 1991 Mar 15;77(6):1283-9. Blood. 1991. PMID: 1900445 Free article.

7

Possible mechanism of action of interferon alpha in chronic B-cell malignancies.

Heslop HE, Brenner MK, Ganeshaguru K, Hoffbrand AV. Heslop HE, et al. Br J Haematol. 1991 Oct;79 Suppl 1:14-6. doi: 10.1111/j.1365-2141.1991.tb08111.x. Br J Haematol. 1991. PMID: 1931702 Review.

8

Graft versus leukaemia effects after marrow transplantation in man.

Brenner MK, Heslop HE. Brenner MK, et al. Among authors: heslop he. Baillieres Clin Haematol. 1991 Jul;4(3):727-49. doi: 10.1016/s0950-3536(09)90010-5. Baillieres Clin Haematol. 1991. PMID: 1958889 Review.

9

Interleukin-2 infusion after autologous bone marrow transplantation enhances hemopoietic regeneration.

Heslop HE, Duncombe AS, Reittie JE, Bello-Fernandez C, Gottlieb DJ, Prentice HG, Hoffbrand AV, Brenner MK. Heslop HE, et al. Transplant Proc. 1991 Feb;23(1 Pt 2):1704-5. Transplant Proc. 1991. PMID: 1989334 No abstract available.

10

Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation.

Heslop HE, Duncombe AS, Reittie JE, Bello-Fernandez C, Gottlieb DJ, Prentice HG, Mehta AB, Hoffbrand AV, Brenner MK. Heslop HE, et al. Br J Haematol. 1991 Feb;77(2):237-44. doi: 10.1111/j.1365-2141.1991.tb07983.x. Br J Haematol. 1991. PMID: 2004026

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

424 results

Search Page

Filters